Trenton, NJ — BioNJ announced that Governor Chris Christie had declared March 2017 as New Jersey Life Sciences Month.
Life Sciences Month was established to raise awareness of the robust medical innovation taking place in New Jersey and highlights the important impact that the industry has on New Jersey's economy.
Click here to view Governor Christie's signed Proclamation.
Known as “The Medicine Chest of the World,” New Jersey is home to nearly 3,200 life sciences establishments, including more than 400 biotechnology companies as well as 14 of the world's largest biopharmaceutical companies and 12 of the 22 top research and development companies.
Life Sciences Month was established to raise awareness of the robust medical innovation taking place in New Jersey and highlights the important impact that the industry has on New Jersey's economy.
Click here to view Governor Christie's signed Proclamation.
Known as “The Medicine Chest of the World,” New Jersey is home to nearly 3,200 life sciences establishments, including more than 400 biotechnology companies as well as 14 of the world's largest biopharmaceutical companies and 12 of the 22 top research and development companies.
Throughout the month, numerous industry activities have showcased the many contributions that New Jersey's life sciences ecosystem is making to advance medical research, support Patients, maximize our robust talent pool, foster STEM education and contribute to the State's economy.
Recognizing that Patients Can't Wait® , on Wednesday, March 22, BioNJ observed a Moment of Hope.
During this time, some of the BioNJ Team came together to reflect upon the needs of Patients and their families. BioNJ created a mural paying tribute to loved ones lost as well as those still hoping for new medical innovation.
Recognizing that Patients Can't Wait® , on Wednesday, March 22, BioNJ observed a Moment of Hope.
During this time, some of the BioNJ Team came together to reflect upon the needs of Patients and their families. BioNJ created a mural paying tribute to loved ones lost as well as those still hoping for new medical innovation.
